These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 27455999)
1. Going Beyond Administrative Data: Retrospective Evaluation of an Algorithm Using the Electronic Health Record to Help Identify Bleeding Events Among Hospitalized Medical Patients on Warfarin. Moriarty JP; Daniels PR; Manning DM; O'Meara JG; Ou NN; Berg TM; Haag JD; Roellinger DL; Naessens JM Am J Med Qual; 2017; 32(4):391-396. PubMed ID: 27455999 [TBL] [Abstract][Full Text] [Related]
2. Discrepancies in identification of major bleeding events in patients taking warfarin. Seto AC; Kenyon K; Wittkowsky AK Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the coding accuracy of warfarin-related bleeding events. Delate T; Jones AE; Clark NP; Witt DM Thromb Res; 2017 Nov; 159():86-90. PubMed ID: 29035718 [TBL] [Abstract][Full Text] [Related]
4. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. Roughead EE; Barratt JD; Ramsay E; Pratt N; Ryan P; Peck R; Killer G; Gilbert AL J Clin Pharm Ther; 2011 Feb; 36(1):27-32. PubMed ID: 21108651 [TBL] [Abstract][Full Text] [Related]
5. Warfarin Therapy After Mechanical Valve Replacement: A Tool for Predicting Bleeding Events. Jang I; Choo S; Kim K J Heart Valve Dis; 2017 Mar; 26(2):215-233. PubMed ID: 28820554 [TBL] [Abstract][Full Text] [Related]
6. Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data. Menzin J; Preblick R; Friedman M; Menzin J; Frean M; Jacqueline Kwong W Hosp Pract (1995); 2014 Oct; 42(4):59-74. PubMed ID: 25502130 [TBL] [Abstract][Full Text] [Related]
7. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO; Lal L; Brown EN; Braun UK J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786 [TBL] [Abstract][Full Text] [Related]
8. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Arnason T; Wells PS; van Walraven C; Forster AJ Thromb Res; 2006; 118(2):253-62. PubMed ID: 16081144 [TBL] [Abstract][Full Text] [Related]
11. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704 [TBL] [Abstract][Full Text] [Related]
12. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics. White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014 [TBL] [Abstract][Full Text] [Related]
13. Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol. Li G; Holbrook A; Delate T; Witt DM; Levine MA; Thabane L BMJ Open; 2015 Nov; 5(11):e009518. PubMed ID: 26546146 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery. Meijer K; Kim YK; Carter D; Schulman S Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999 [TBL] [Abstract][Full Text] [Related]
15. Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries. Mosholder AD; Racoosin JA; Young S; Wernecke M; Shoaibi A; MaCurdy TE; Worrall C; Kelman JA Ann Pharmacother; 2013 Nov; 47(11):1420-8. PubMed ID: 24285759 [TBL] [Abstract][Full Text] [Related]
16. Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty. Clark NP; Cho SE; Delate T; Witt DM Thromb Res; 2013 May; 131(5):390-5. PubMed ID: 23522854 [TBL] [Abstract][Full Text] [Related]
17. Development of a contemporary bleeding risk model for elderly warfarin recipients. Shireman TI; Mahnken JD; Howard PA; Kresowik TF; Hou Q; Ellerbeck EF Chest; 2006 Nov; 130(5):1390-6. PubMed ID: 17099015 [TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study. Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP; Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635 [TBL] [Abstract][Full Text] [Related]
19. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033 [TBL] [Abstract][Full Text] [Related]
20. Evaluating warfarin management by pharmacists in a community teaching hospital. Chilipko AA; Norwood DK Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]